4basebio logo

4basebio jobs and careers

Cambridge, United Kingdom

About 4basebio

4basebio is enabling next generation cell and gene therapies and vaccines with its technologies and solutions. We are able to design, manufacture and supply application-specific synthetic DNA or mRNA as well as targeted non-viral vectors for the delivery of nucleic acid payloads. Our novel synthetic DNA technology offers unique customisation potential, rapid turn-around times, and improved safety profiles, addressing the current limitations of plasmids and other DNA technologies. We currently offer four DNA construct types, each ideally suited for use in viral and non-viral vector applications, genome editing, vaccines and therapeutics, and DNA vaccine applications, respectively. Our proprietary non-viral delivery system, Hermes™, is a nanoparticle vector that can be customised to target cells or tissues of interest for a range of applications. This combines the safety and efficiency of lipid-based nanoparticles (LNPs) with the specificity of a targeting system, addressing the shortcoming associated with both viral vectors and non-targeted LNPs.

Founded
1997
Employees
11 to 50
Total funding
$299K
Headquarters
Cambridge

Leadership

The top of 4basebio's org chart, with how many people report into each leader.

HL

Heikki Lanckriet

CEO/Chief Scientific Officer

59 reports

AWPhoto of Amy Walker

Amy Walker

Chief Executive Officer

20 reports

ZWPhoto of Zoe Whiffen

Zoe Whiffen

Senior Director - RUO Operations / MSAT

15 reports

JH

Jennifer Hynes

VP of Quality

12 reports

CWPhoto of Christine Wolosin

Christine Wolosin

Chief Commercial Officer

6 reports

DRPhoto of David Roth

David Roth

CFO

1 report